Cargando…
Triple negative aggressive phenotype controlled by miR-135b and miR-365: new theranostics candidates
Triple negative breast cancer (TNBC) accounts for about a fifth of all breast cancers and includes a diverse group of cancers. The heterogeneity of TNBC and the lack of target receptors on the cell surface make it difficult to develop specific therapeutic treatments. These aspects cause the high neg...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985188/ https://www.ncbi.nlm.nih.gov/pubmed/33753785 http://dx.doi.org/10.1038/s41598-021-85746-w |